Avenue Therapeutics Files 2024 10-K
Ticker: ATXI · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1644963
Sentiment: neutral
Topics: 10-K, financials, pharmaceutical
TL;DR
AVTX 2024 10-K filed. Financials show preferred/common stock details. Check for updates.
AI Summary
Avenue Therapeutics, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company's primary focus is on the development of therapies, with significant financial figures related to its operations and capital structure detailed within the filing. Key financial data includes details on preferred and common stock, as well as additional paid-in capital.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Avenue Therapeutics' financial health and operational status for the fiscal year 2024, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical development company, Avenue Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2,000,000 — Preferred Shares (Number of preferred shares outstanding)
- 200,000,000 — Authorized Common Shares (Maximum number of common shares authorized)
- 2,108,670 — Issued Common Shares (Number of common shares issued)
- 75,000,000 — Authorized Preferred Shares (Maximum number of preferred shares authorized)
Key Players & Entities
- AVENUE THERAPEUTICS, INC. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
- DE (state) — State of incorporation
- 781-652-4500 (phone_number) — Business phone number
FAQ
What is the total number of common shares outstanding as of December 31, 2024?
As of December 31, 2024, there were 2,108,670 common shares issued.
What is the total number of preferred shares authorized?
The company has authorized 75,000,000 preferred shares.
When was Avenue Therapeutics, Inc. incorporated?
Avenue Therapeutics, Inc. is incorporated in Delaware (DE).
What is the company's SIC code?
The Standard Industrial Classification (SIC) code for Avenue Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of Avenue Therapeutics, Inc.?
The business address is 1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL 33154.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding AVENUE THERAPEUTICS, INC. (ATXI).